Rama Phosphates Achieves 52-Week High Amid Strong Financial Performance and Market Position
Rama Phosphates has achieved a new 52-week high, driven by a strong stock performance over the past eight days. The company reported impressive quarterly results, including significant growth in operating profit and profit before tax. Its low Debt to EBITDA ratio and consistent positive results enhance its market position in the fertilizer sector.
Rama Phosphates has made headlines today as its stock price reached a new 52-week high of Rs. 161.8, marking a significant milestone for the microcap fertilizer company. This achievement comes after a remarkable performance, with the stock gaining 24.94% over the past eight consecutive days, outperforming its sector by 2.05%. The company's financial health is underscored by a low Debt to EBITDA ratio of 0.87 times, indicating a strong ability to service its debt. Recent quarterly results have been impressive, showcasing an 88.76% growth in operating profit and a staggering 667% increase in profit before tax compared to previous averages. Additionally, the company has consistently reported positive results for the last three quarters, further solidifying its market position.
Over the past year, Rama Phosphates has generated a remarkable return of 70.50%, significantly outpacing the BSE500 index, which recorded a mere 1.06% return. With a fair valuation and a PEG ratio of 0.2, the stock is currently trading at a discount compared to its peers. Despite some risks associated with long-term growth, the company's recent performance metrics highlight its potential in the competitive fertilizer industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
